file

Pretest self-assessment question (answer at the end of the case)


Which of the following evidence-based antidepressant augmentations likely has the least side-effect burden?




A. SAMe



B. Lithium carbonate



C. Aripiprazole



D. Thyroid hormone






Patient evaluation on intake




  • 52-year-old man cannot sleep



  • He has been “in a funk” for about a year after he had difficulty at his work site



Psychiatric history




  • The patient has been emotionally well his whole life



  • About a year ago, developed vision problems due to diabetes, which interfered with his ability to work safely at his job site as an assembly line worker



  • He was placed on lighter duty and then ultimately laid off due to bad economic times



  • At the time of his transition to light duty, he began experiencing psychiatric symptoms as follows




    • Insomnia



    • Dysphoria and irritability



    • Increasing anhedonia



    • Poor concentration



    • Poor appetite



    • Feelings of worthlessness and hopelessness



    • Fatigue



    • He denied suicidal thoughts, or psychotic, manic, anxiety, and substance misuse symptoms



Social and personal history




  • Married with five adult children



  • Takes care of his grandchildren often and might be considered a primary caregiver



  • Has tenth grade education



  • Gainfully employed as an assembly line worker for many years until recently



  • Most of his friends, support, and identity as an autoworker were disrupted when he was forced to leave work



  • He does not abuse substances, nicotine, or caffeine



Medical history




  • Suffers from DM2 with worsening vision, renal function, and neuropathy in his feet



  • Has HTN and hyperlipidemia



  • He has good attendance and follow-up with his PCP and currently has these metabolic disorders well controlled



Family history




  • One son has bipolar disorder and substance abuse problems



  • Mother suffered from MDD



  • AUD is present in multiple family members at each generation



Medication history




  • PCP started him on the SSRI sertraline (Zoloft) 50 mg/d three weeks ago




    • Sleep is starting to improve somewhat and there is less noticeable irritability



    • Complains now that his hands feel “greasy and tacky”




      • Feels like he has residual car “motor oil on them” all the time



      • Washes his hands to no avail



      • There are no rashes or skin changes on examination



Psychotherapy history




  • Started supportive psychotherapy several weeks ago



  • Attendance is good



  • Feels better after sessions but this is short lived



Patient evaluation on initial visit




  • Patient suffers from new-onset MDD



  • He is somewhat better but dislikes the side effects in his hands as they “feel greasy”



Current medications




  • Sertraline (Zoloft) 50 mg/d (SSRI)



  • Insulin sliding scale



  • Atorvastatin (Lipitor) 40 mg/d



  • Metoprolol (Toprol-XL) 100 mg/d



  • Metformin (Glucophage) 2000 mg/d



Question


Greasy hands? Is that a real side effect?




  • No, it is hypochondriacal, hysterical, or a nocebo side effect



  • No, it is not listed in the regulatory package insert for sertraline



  • Yes, a web search reveals that two to three other patients have posted similar experiences



  • Yes, it is likely a paresthesia, and these occur in 1% of patients taking sertraline



  • Yes, it is a side effect because the patient says it is, and it bothers him



Attending physician’s mental notes: initial evaluation




  • This patient has an index episode of MDD that is moderate in severity



  • This was likely initiated due to an interpersonal loss and social stressor when his working career ended beyond his control



  • He may be starting to respond to his inaugural SSRI at this time, but has a strange side effect where his hands feel greasy, or as if they were immersed in liquid



  • He does not appear to have any comorbid psychiatric conditions



  • He has some chronic medical problems but they appear stable and well controlled



  • He is not felt to be suicidal



Question


Which of the following would be your next step?




  • Do nothing as his SSRI is starting to become effective after three weeks of use



  • His side effects are strange but minor; convince him to tolerate his medication longer



  • Increase the SSRI for better effect



  • Change to an alternate SSRI in the hope of continuing this early efficacy but without the paresthesia



  • Change classes to a different family of antidepressant



  • Add an anti-paresthesia medication such as gabapentin (Neurontin)



  • Refer for specific IPT, which is well studied for depression when caused by interpersonal role change such as a loss of work



Attending physician’s mental notes: initial evaluation (continued)




  • The patient is somewhat better after three weeks of SSRI treatment, but this equates to 20% better at most, as only two MDD symptoms are minimally better



  • If patient can tolerate his side effect a bit more and given this initial small response, it may make sense to increase his current SSRI, sertraline (Zoloft) further



Further investigation


Is there anything else you would especially like to know about this patient?




  • Could there be any other cause to the strange sensations in his hands?




    • Physical examination reveals no clear skin changes or deformities



    • He has full range of motion, no arthritic changes



    • He has no history of cervical injury or pain



    • None of the medications are known to cause this kind of side effect



    • There is no evidence of carpal tunnel or other entrapment syndrome



    • Discussions with his PCP confirms these findings



    • He has leg pain and neuropathy from his diabetes, it is possible that these hand pressure sensations are the start of diabetic neuropathy in his upper extremities that presented coincidentally with the start of his SSRI



Case outcome: first interim follow-up visits through three months




  • Agrees now to increase the SSRI sertraline (Zoloft) to 100 mg/d and to tolerate the side effect of greasy hands as it is explained that it may be a rare side effect or part of his DM2



  • Later feels better but qualifies this as being less ruminative, less tense, and sleeping better, but still often feels amotivated and dysphoric



  • The SSRI dose is raised to 150 mg/d and he returns with moderate, sustained improvement in these symptoms and he feels his appetite is better



Question


Do the SSRIs have a dose–response curve where greater doses treat a greater number of symptoms?




  • No, according to regulatory information, there is no additional benefit between low, moderate, and high doses of SSRI when used to treat MDD



  • No, studies suggest that low doses of SSRI successfully inhibit the SERT, indicating that further inhibition is likely not needed for greater antidepressant response



  • Yes, in clinical practice, many clinicians claim that higher doses usually aid in more symptom reduction



  • Yes, textbooks and a recret meta-analysis suggest higher dosing on an individual basis to deliver the highest effectiveness



  • Possibly, as regulatory trials often contain 300–400 subjects and are statistically designed to show that all doses are superior to placebo but not necessarily to each other




    • They are not designed with enough subjects, i.e., 1500 or enough statistical power to show discrete differences between low, middle, and higher doses

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 16, 2017 | Posted by in PHARMACY | Comments Off on file

Full access? Get Clinical Tree

Get Clinical Tree app for offline access